Close
ACHEMA MIDDLE EAST 2026

Tag: Asia Pacific

Advancing Asia-Pacific Healthcare & Biopharma Innovation

In order to improve healthcare and hasten drug research in their home markets, some Asian-Pacific municipal governments have established sensible policies and laws within...

Global Biopharma Market to Hit $566B by 2032

Global Biopharma Market Forecasts $566B By 2032 opposing Challenges With a compound annual growth rate of almost 8%, from $263 billion in 2022 to $566...

The Great Hall of China: double digit growth at CPhI China

CPhI and P-MEC China , UBM Sinoexpo,CCCMHPIE,Chinese pharmaceutical market development,Asia’s largest pharma event CPhI and P-MEC China, organised by UBM EMEA, UBM Sinoexpo and China...

Daiichi Sankyo Announces ENLIVEN Phase 3 Study of Pexidartinib Met Primary Endpoint in Tenosynovial Giant Cell Tumor

Daiichi Sankyo Company, Limited announced that the pivotal phase 3 placebo-controlled ENLIVEN (NCT02371369) study of pexidartinib met its primary endpoint of tumor response as...

BERG Enters Into An Agreement With Sanofi Pasteur To Identify Biomarkers Of Flu Vaccine Performance

BERG, a biopharmaceutical company that merges biology with technology announced a new research effort with Sanofi Pasteur, the influenza vaccine global leader. ...

Popular